Literature DB >> 18551608

Concomitant diffuse large B-cell lymphoma and hepatocellular carcinoma in chronic hepatitis C virus liver disease: a study of two cases.

Amy Lin1, Jaydeep S Kadam, Henry C Bodenheimer, John Leonard, Maureen A Joyce, Gerond Lake-Bakaar.   

Abstract

Chronic hepatitis C virus HCV infection progresses through liver fibrosis and cirrhosis to hepatocellular carcinoma HCC. It appears to be causally related to B-cell non-Hodgkin's lymphoma since regression after antiviral therapy has been described. Two cases are described of non-Hodgkin's lymphoma and HCC arising simultaneously in two patients. The first patient did not have cirrhosis on liver biopsy. HCV had been undetectable in plasma following successful therapy with interferon and ribavirin treatment 7 years earlier. The second patient developed an aggressive form of hepatocellular carcinoma HCC within weeks of stopping treatment with interferon and ribavirin. Therapy had induced complete viral suppression for over 40 weeks. The two cases suggest that non-Hodgkin's lymphoma and HCC can develop in the absence of detectable hepatitis C viremia and argues for continued surveillance even after sustained virological response to treatment.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18551608     DOI: 10.1002/jmv.21109

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  4 in total

1.  Hepatocellular carcinoma infiltrated with non-Hodgkin's lymphoma: report of a case.

Authors:  Tohru Utsunomiya; Masahiro Okamoto; Eiji Tsujita; Manabu Yamamoto; Shinichi Tsutsui; Megumu Fujihara; Teruyoshi Ishida
Journal:  Surg Today       Date:  2009-11-01       Impact factor: 2.549

2.  Repeat hepatectomies for hepatic malignant lymphoma and hepatocellular carcinoma associated with chronic hepatitis C: report of a case.

Authors:  Hirotada Tajiri; Keishi Sugimachi; Nao Kinjo; Masahiko Ikebe; Junko Tanaka; Kiyoshi Tanaka; Shuichi Tsukamoto; Shinsuke Mii; Eiji Kajiwara; Tatsuro Shimokama; Hidefumi Higashi
Journal:  Surg Today       Date:  2013-02-13       Impact factor: 2.549

3.  Diagnosis and Treatment of Synchronous Lymphoma and Digestive System Carcinoma: Report of Four Cases and Literature Review.

Authors:  Jingshu Meng; Huaxiong Pan; Xiaoqian Li; Tao Liu; Zijian Liu; Qiuhui Li; Yin Xiao; Xinxiu Liu; Gang Wu; Fang Zhu; Liling Zhang
Journal:  Front Oncol       Date:  2019-12-10       Impact factor: 6.244

4.  Case Report: Clinical Responses to Tislelizumab as a First-Line Therapy for Primary Hepatocellular Carcinoma With B-Cell Indolent Lymphoma.

Authors:  Qijun Li; Yong Dong; Yubin Pan; Honglin Tang; Da Li
Journal:  Front Immunol       Date:  2021-03-31       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.